| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1030521684 |
| P356 | DOI | 10.1007/S12519-013-0426-0 |
| P698 | PubMed publication ID | 23929253 |
| P50 | author | Claudio Pignata | Q30512461 |
| Pietro Vajro | Q58423442 | ||
| P2093 | author name string | Giancarlo Parenti | |
| Mariacarolina Salerno | |||
| Claudio Veropalumbo | |||
| Sergio Maddaluno | |||
| P2860 | cites work | Treatment of hepatitis C in children: a systematic review | Q21136318 |
| An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases | Q24632766 | ||
| Partially randomized, non-blinded trial of DNA and MVA therapeutic vaccines based on hepatitis B virus surface protein for chronic HBV infection | Q28742762 | ||
| EASL clinical practice guidelines: Management of chronic hepatitis B virus infection | Q29615868 | ||
| Lamivudine in late pregnancy to interrupt in utero transmission of hepatitis B virus: a systematic review and meta-analysis | Q33611824 | ||
| Tenofovir-associated bone density loss | Q33635034 | ||
| HBV therapy: guidelines and open issues | Q34025181 | ||
| Structural basis for broad neutralization of hepatitis C virus quasispecies | Q34064882 | ||
| Hepatitis C treatment: current and future perspectives | Q34147323 | ||
| Progress in the development of preventive and therapeutic vaccines for hepatitis C virus | Q34159081 | ||
| Peginterferon and ribavirin treatment for hepatitis C virus infection | Q34521371 | ||
| Guidelines for the screening and follow-up of infants born to anti-HCV positive mothers | Q35180925 | ||
| Long term effect of alpha interferon in children with chronic hepatitis B. | Q35360056 | ||
| Virologic responses to add-on adefovir dipivoxil treatment versus entecavir monotherapy in children with lamivudine-resistant chronic hepatitis B | Q84355940 | ||
| HBV DNA suppression during entecavir treatment in previously treated children with chronic hepatitis B. | Q35828225 | ||
| A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: 2008 update | Q37290723 | ||
| EASL Clinical Practice Guidelines: management of chronic hepatitis B. | Q37340737 | ||
| Management of chronic hepatitis B in children. | Q37423706 | ||
| Chronic hepatitis C virus infection in children. | Q37663746 | ||
| Treatment of viral hepatitis B in children | Q37702241 | ||
| Treatment of children with chronic hepatitis B virus infection in the United States: Patient selection and therapeutic options | Q37796726 | ||
| Therapeutic vaccines and immune-based therapies for the treatment of chronic hepatitis B: perspectives and challenges | Q37828959 | ||
| Treatment of chronic hepatitis B: update of the recommendations from the 2007 Italian Workshop. | Q37833228 | ||
| Review article: current antiviral therapy of chronic hepatitis B. | Q37943006 | ||
| Pediatric hepatitis C infection: to treat or not to treat...what's the best for the child? | Q37947635 | ||
| New therapies for chronic hepatitis C infection: a systematic review of evidence from clinical trials | Q37993889 | ||
| NASPGHAN practice guidelines: Diagnosis and management of hepatitis C infection in infants, children, and adolescents | Q38001268 | ||
| Hepatitis B virus infection and pregnancy: a practical approach. | Q38004993 | ||
| Chronic hepatitis B in children and adolescents | Q38013464 | ||
| Guidance for clinical trials for children and adolescents with chronic hepatitis C. | Q39817353 | ||
| Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection in children and adolescents | Q40361081 | ||
| Management of chronic hepatitis B in childhood: ESPGHAN clinical practice guidelines: consensus of an expert panel on behalf of the European Society of Pediatric Gastroenterology, Hepatology and Nutrition. | Q42261635 | ||
| Single-nucleotide polymorphisms of IL-10 and IL-28B as predictors of the response of IFN therapy in HCV genotype 4-infected children. | Q42281913 | ||
| Tenofovir disoproxil fumarate and bone mineral density: a 60-month longitudinal study in a cohort of HIV-infected youths. | Q42839637 | ||
| Long-term course of chronic hepatitis C in children: from viral clearance to end-stage liver disease | Q42978075 | ||
| Safety and antiviral activity of albinterferon alfa-2b in prior interferon nonresponders with chronic hepatitis C. | Q42983717 | ||
| Genetic variation in interleukin-28B locus is associated with spontaneous clearance of HCV in children with non-1 viral genotype infection | Q43037732 | ||
| Discovery and development of telaprevir: an NS3-4A protease inhibitor for treating genotype 1 chronic hepatitis C virus | Q43042207 | ||
| Lamivudine and adefovir resistance in children and young adults with chronic hepatitis B. | Q43295858 | ||
| Forty-eight-week retrospective study of telbivudine and lamivudine treatment in patients with hepatitis B-related cirrhosis | Q43970369 | ||
| Evolution of adefovir-resistant HBV polymerase gene variants after switching to tenofovir disoproxil fumarate monotherapy | Q44071464 | ||
| Lymphoblastoid interferon alfa with or without steroid pretreatment in children with chronic hepatitis B: a multicenter controlled trial | Q44296848 | ||
| Children unresponsive to hepatitis B virus vaccination also need celiac disease testing | Q45357720 | ||
| Tenofovir disoproxil fumarate for prevention of vertical transmission of hepatitis B virus infection by highly viremic pregnant women: a case series | Q45357942 | ||
| Risk factors for mother-to-child transmission of hepatitis C virus: Maternal high viral load and fetal exposure in the birth canal | Q45359075 | ||
| Perinatal transmission of hepatitis B virus: an Australian experience | Q45384871 | ||
| Safety, efficacy, and pharmacokinetics of adefovir dipivoxil in children and adolescents (age 2 to <18 years) with chronic hepatitis B. | Q46629936 | ||
| Efficacy and tolerance of a combination of tenofovir disoproxil fumarate plus emtricitabine in patients with chronic hepatitis B: a European multicenter study. | Q46644424 | ||
| Long-term lamivudine therapy for children with HBeAg-positive chronic hepatitis B. | Q46914193 | ||
| Interferon alfa therapy for chronic hepatitis B in children: a multinational randomized controlled trial. | Q50893939 | ||
| Report on a single-topic conference on "Chronic viral hepatitis--strategies to improve effectiveness of screening and treatment". | Q50991688 | ||
| Randomized, placebo-controlled trial of tenofovir disoproxil fumarate in adolescents with chronic hepatitis B | Q61974430 | ||
| Prolonged and high dose recombinant interferon alpha-2b alone or after prednisone priming accelerates termination of active viral replication in children with chronic hepatitis B infection | Q71644652 | ||
| Long-term interferon-alpha treatment of children with chronic hepatitis delta: a multicentre study | Q71688222 | ||
| Long-term outcome in children with chronic hepatitis B: a 24-year observation period | Q81321022 | ||
| Telbivudine prevents vertical transmission from HBeAg-positive women with chronic hepatitis B | Q83462911 | ||
| P433 | issue | 3 | |
| P921 | main subject | viral hepatitis | Q1983841 |
| P304 | page(s) | 212-220 | |
| P577 | publication date | 2013-08-09 | |
| P1433 | published in | World Journal of Pediatrics | Q15763275 |
| P1476 | title | Treatment of children with chronic viral hepatitis: what is available and what is in store | |
| P478 | volume | 9 |
| Q50019524 | A Multicenter Study of the Antiviral Efficacy of Entecavir Monotherapy Compared to Lamivudine Monotherapy in Children with Nucleos(t)ide-naïve Chronic Hepatitis B. |
| Q38692198 | An update on the strategies used for the treatment of chronic hepatitis B in children. |
| Q26781770 | Chronic Hepatitis C Infection in Children: Current Treatment and New Therapies |
| Q47571145 | Optimizing Research to Speed Up Availability of Pediatric Antiretroviral Drugs and Formulations |
Search more.